MAP3K1 and glioblastoma: More recent studies have identified several molecular alterations in glioblastoma that are associated with radio‐ or chemo‐resistance and poor prognosis in clinic, for example, B3GNT5,44 elevation of CXCL145 or TRIB2 and MAP3K1,46 and COPB2.47